# Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy

> **NCT07090278** · — · COMPLETED · sponsor: **Shusheng Li** · enrollment: 2734 (actual)

## Conditions studied

- Sepsis-Associated Encephalopathy

## Interventions

- **DRUG:** ulinastatin

## Key facts

- **NCT ID:** NCT07090278
- **Lead sponsor:** Shusheng Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-11-30
- **Target enrollment:** 2734 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07090278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07090278, "Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07090278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*